Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data
Abstract Resistin has been firmly associated with all-cause mortality. We investigated, whether, in patients with type 2 diabetes (T2D), this association is sustained by a cause-effect relationship. A genotype risk score (GRS), created by summing the number of resistin increasing alleles of two geno...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/90daf3af87b44763b1ffa3bf67c24cdb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:90daf3af87b44763b1ffa3bf67c24cdb |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:90daf3af87b44763b1ffa3bf67c24cdb2021-12-02T11:52:33ZSerum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data10.1038/s41598-017-00138-32045-2322https://doaj.org/article/90daf3af87b44763b1ffa3bf67c24cdb2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00138-3https://doaj.org/toc/2045-2322Abstract Resistin has been firmly associated with all-cause mortality. We investigated, whether, in patients with type 2 diabetes (T2D), this association is sustained by a cause-effect relationship. A genotype risk score (GRS), created by summing the number of resistin increasing alleles of two genome-wide association studies (GWAS)-derived single nucleotide polymorphisms (SNPs), serum resistin measurements and all-cause death records were obtained in 1,479 (403 events/12,454 person-years), patients with T2D from three cohorts, Gargano Heart Study-prospective design (n = 350), Gargano Mortality Study (n = 698) and Foggia Mortality Study (n = 431), from Italy. GRS was strongly associated with serum resistin in a non-linear fashion (overall p = 3.5 * 10−7) with effect size modest for GRS = 1 and 2 and much higher for GRS >3, with respect to GRS = 0. A significant non-linear association was observed also between GRS and all-cause mortality (overall p = 3.3 * 10−2), with a low effect size for GRS = 1 and 2, and nearly doubled for GRS ≥ 3, with respect to GRS = 0. Based on the above-reported associations, each genetic equivalent SD increase in log-resistin levels showed a causal hazard ratio of all-cause mortality equal to 2.17 (95%CI: 1.22–3.87), thus providing evidence for a causal role of resistin in shaping the risk of mortality in diabetic patients.Andrea FontanaLorena Ortega MorenoOlga LamacchiaConcetta De BonisLucia SalveminiSalvatore De CosmoMauro CignarelliMassimiliano CopettiVincenzo TrischittaClaudia MenzaghiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-6 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Andrea Fontana Lorena Ortega Moreno Olga Lamacchia Concetta De Bonis Lucia Salvemini Salvatore De Cosmo Mauro Cignarelli Massimiliano Copetti Vincenzo Trischitta Claudia Menzaghi Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| description |
Abstract Resistin has been firmly associated with all-cause mortality. We investigated, whether, in patients with type 2 diabetes (T2D), this association is sustained by a cause-effect relationship. A genotype risk score (GRS), created by summing the number of resistin increasing alleles of two genome-wide association studies (GWAS)-derived single nucleotide polymorphisms (SNPs), serum resistin measurements and all-cause death records were obtained in 1,479 (403 events/12,454 person-years), patients with T2D from three cohorts, Gargano Heart Study-prospective design (n = 350), Gargano Mortality Study (n = 698) and Foggia Mortality Study (n = 431), from Italy. GRS was strongly associated with serum resistin in a non-linear fashion (overall p = 3.5 * 10−7) with effect size modest for GRS = 1 and 2 and much higher for GRS >3, with respect to GRS = 0. A significant non-linear association was observed also between GRS and all-cause mortality (overall p = 3.3 * 10−2), with a low effect size for GRS = 1 and 2, and nearly doubled for GRS ≥ 3, with respect to GRS = 0. Based on the above-reported associations, each genetic equivalent SD increase in log-resistin levels showed a causal hazard ratio of all-cause mortality equal to 2.17 (95%CI: 1.22–3.87), thus providing evidence for a causal role of resistin in shaping the risk of mortality in diabetic patients. |
| format |
article |
| author |
Andrea Fontana Lorena Ortega Moreno Olga Lamacchia Concetta De Bonis Lucia Salvemini Salvatore De Cosmo Mauro Cignarelli Massimiliano Copetti Vincenzo Trischitta Claudia Menzaghi |
| author_facet |
Andrea Fontana Lorena Ortega Moreno Olga Lamacchia Concetta De Bonis Lucia Salvemini Salvatore De Cosmo Mauro Cignarelli Massimiliano Copetti Vincenzo Trischitta Claudia Menzaghi |
| author_sort |
Andrea Fontana |
| title |
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| title_short |
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| title_full |
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| title_fullStr |
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| title_full_unstemmed |
Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| title_sort |
serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/90daf3af87b44763b1ffa3bf67c24cdb |
| work_keys_str_mv |
AT andreafontana serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT lorenaortegamoreno serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT olgalamacchia serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT concettadebonis serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT luciasalvemini serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT salvatoredecosmo serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT maurocignarelli serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT massimilianocopetti serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT vincenzotrischitta serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata AT claudiamenzaghi serumresistiniscausallyrelatedtomortalityriskinpatientswithtype2diabetespreliminaryevidencesfromgeneticdata |
| _version_ |
1718394996064780288 |